Maalox Plus 200 mg/175 mg/25 mg Oral Suspension

Šalis: Airija

kalba: anglų

Šaltinis: HPRA (Health Products Regulatory Authority)

Veiklioji medžiaga:

Aluminium hydroxide; Magnesium hydroxide; Simeticone

Prieinama:

Sanofi-Aventis Ireland Limited T/A SANOFI

ATC kodas:

A02AF; A02AF02

INN (Tarptautinis Pavadinimas):

Aluminium hydroxide; Magnesium hydroxide; Simeticone

Dozė:

200 mg/175 mg/25 mg/5ml

Vaisto forma:

Oral suspension

Recepto tipas:

Product not subject to medical prescription

Gydymo sritis:

Antacids with antiflatulents; ordinary salt combinations and antiflatulents

Autorizacija statusas:

Marketed

Leidimo data:

1975-11-10

Pakuotės lapelis

MAALOX® PLUS 200MG/175MG/25MG PER 5ML
ORAL SUSPENSION
_magnesium hydroxide _
_aluminium hydroxide _
_simethicone _
_ _
IS THIS LEAFLET HARD TO SEE OR READ?
PHONE [phone] FOR HELP
READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU
This medicine is available without prescription. However, you still
need to use Maalox Plus Oral
Suspension carefully to get the best results from it.
• Keep this leaflet. You may need to read it again
• Ask your pharmacist if you need more information or advice
• If you get any side effects, talk to your doctor or pharmacist.
This includes any possible side effects
not listed in this leaflet.
• You must talk to a doctor if you do not feel better or if you feel
worse after taking this medicine.
IN THIS LEAFLET:
1. WHAT MAALOX PLUS ORAL SUSPENSION IS AND WHAT IT IS USED FOR
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MAALOX PLUS ORAL SUSPENSION
3. HOW TO TAKE MAALOX PLUS ORAL SUSPENSION
4. POSSIBLE SIDE EFFECTS
5. HOW TO STORE MAALOX PLUS ORAL SUSPENSION
6. CONTENTS OF THE PACK AND OTHER INFORMATION
1. WHAT MAALOX PLUS ORAL SUSPENSION IS AND WHAT IT IS USED FOR
Maalox Plus Oral Suspension contains three different medicines:
• The first two medicines are called magnesium hydroxide and
aluminium hydroxide. They belong to
a group of medicines called antacids.
• The other medicines is called simeticone. It belongs to a group of
medicines called anti-foaming
agents.
Maalox Plus Oral Suspension is used for:
• The relief of indigestion (dyspepsia)
• Heartburn
• Wind (flatulence)
Maalox Plus Oral Suspension works by lowering the amount of acid in
your stomach. The anti-
foaming agents in Maalox Plus Oral Suspension helps to remove gas from
your stomach.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MAALOX PLUS ORAL SUSPENSION
DO NOT TAKE MAALOX PLUS ORAL SUSPENSION IF:
• You are allergic (hypersensitive) to magnesium hydroxide,
aluminium hydroxide, simeticone or any
of the other ingredients in Maalox Plus Oral Suspension (see Section
6: Contents

Prekės savybės

Health Products Regulatory Authority
15 March 2021
CRN009V1S
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Maalox Plus 200 mg/175 mg/25 mg Oral Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 5 ml of the suspension contains:
200 mg of Magnesium Hydroxide (as Magnesium Hydroxide Paste)
175 mg of Aluminium Hydroxide (as Aluminium Hydroxide Gel ),
25 mg of Simeticone.
Excipients with known effect: Each 5ml also contains 224.85 mg
sorbitol (E420), 1.66mg sodium, 3.667mg ethanol, 3ppm
sulphur dioxide (E220) (3ppm)
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Oral Suspension
A white lemon flavoured oral suspension.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
In the treatment of heartburn, indigestion, flatulence and dyspepsia.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
The route of administration is oral.
Recommended Dosage
Adults: One to two x 5ml spoonfuls four times a day (after meals and
at bedtime) or as required.
Children: Not recommended
4.3 CONTRAINDICATIONS
Use in severely debilitated patients or in those suffering from kidney
failure.
Use in patients who are hypersensitive to the active ingredients or to
any of the excipients.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Aluminium hydroxide may cause constipation and magnesium salts
overdose may cause
hypomotility of the bowel; large doses of this product may trigger or
aggravate intestinal obstruction and ileus in patients at
higher risk such as those with renal impairment, infants less than 2
years, or the elderly..
Aluminium hydroxide is not well absorbed from the gastrointestinal
tract, and systemic effects are therefore rare in patients
with normal renal function. However, excessive doses or long-term use,
or evennormal doses in patients with low-phosphorus
Health Products Regulatory Authority
15 March 2021
CRN009V1S
Page 2 of 5
diets or in infants less than 2 years, may lead tophosphate depletion
(due to aluminium-phosphate binding) accompanied by
increased boneresorption and h